← 產業報告目錄

Empty Capsules Market by Type (Gelatin, Non-gelatin), Raw Material (Porcine, Bovine, HPMC), Functionality (Immediate, Sustained, Delayed), Application (Antibiotic, Dietary, CVD), Size (00 Capsule), End User (Pharma, Nutraceutical) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-08-22頁數 460報告編號 PH2935

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global empty capsules market is projected to reach USD 4.19 billion by 2030 from an estimated USD 3.19 billion in 2025, at a CAGR of 5.6% from 2025 to 2030. The market is fueled by increasing demand for nutraceuticals and personalized supplements, growth in pharmaceutical R&D, and innovations in functional and modified-release capsules. A significant shift toward vegetarian and clean-label options and sustainability-focused regulations is further driving adoption. Future growth is likely to come from localized production in emerging markets and the creation of biodegradable capsules. “The porcine-derived capsules will continue to be the largest raw material segment in the gelatin capsules market, growing at the highest CAGR.” The gelatin empty capsules market is segmented based on raw material into porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin capsules market is further categorized into hydroxypropyl methylcellulose (HPMC) and pullulan & starch. The porcine gelatin capsule market is the largest raw material category and is expected to experience the highest growth rate during the forecast period, due to its cost-effectiveness and wide availability. Porcine gelatin is widely used in the pharmaceutical and nutraceutical industries because of its excellent gelling properties, making it suitable for various drug formulations, including solid and controlled-release types. “Pharmaceutical industry segment reported the highest share of the end user segment in 2024.” Based on end users, the empty capsules market is categorized into pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The pharmaceutical industry is the largest end user of empty capsules, widely using them for delivering prescription drugs, over-the-counter (OTC) medications, and therapeutic treatments. These capsules are commonly used for oral administration of solid drugs like antibiotics, pain relievers, antihypertensives, and other medications for managing chronic diseases. Capsules are a preferred dosage form in the pharmaceutical sector because they are easy to swallow, provide accurate dosing, and can encapsulate a broad range of drugs. North America accounted for the largest global empty capsules market from 2025 to 2030. In 2024, North America, especially the US and Canada, will be the largest market for empty capsules due to strong demand in pharmaceuticals and nutraceuticals, supported by advanced manufacturing infrastructure and robust regulatory frameworks. Ongoing investments in technology and innovation have led to the development of high-quality capsules for various applications, such as immediate and controlled-release drug delivery. The rising demand for dietary supplements, driven by consumer interest in preventive healthcare and wellness, further fuels market growth. The region also benefits from a favorable regulatory environment, which encourages the adoption of new drug delivery formats, including controlled-release and enteric-coated capsules. Additionally, the Asia Pacific region is expected to see the fastest growth during this period, thanks to expanding pharmaceutical manufacturing capabilities, lower production costs, and supportive government policies. Countries like China, India, and South Korea are becoming key manufacturing hubs due to their large skilled labor pools, low costs, and favorable policies. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side-70% and Demand Side-30% • By Designation: Managers-45%, CXO and Directors-30%, and Executives-25% • By Region: North America-40%, Europe-25%, the Asia Pacific-20%, Latin America-10%, and the Middle East & Africa-5% List of Key Companies Profiled in the Report: Key players in the Empty capsules market include Lonza (Capsugel) (Switzerland), ACG (India), Suheung (South Korea), Roquette (Qualicaps) (France), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), Nectar Lifesciences (India), Sunil Healthcare (India), Natural Capsules Limited (India), Baotou Dongbao Bio-Tech Co Ltd. (China), Anhui Huangshan Capsule Co., Ltd. (China), CapsCanada(Lyfe Group) (Canada), Farmacapsulas (Colombia), Healthcaps India (India), Erawat Pharma (India), Comed Chemicals Ltd (India), Fortcaps Healthcare Limited (India), and Shandong Healsee Capsule Ltd. (China). Research Coverage: This research report categorizes the empty capsules market, by type (gelatin capsules, non-gelatin capsules), by raw materials (gelatin [porcine-derived gelatin, bovine-derived gelatin, bone meal-derived gelatin, other gelatin sources], non-gelatin [hpmc, pullulan & starch]), functionality (immediate-release, sustained-release, delayed-release), size (Size 000, Size 00, Size 0, Size 1, Size 2, Size 3, Size 4, Size 5), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & ant flatulent preparations, anti-anaemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications), end user (pharmaceutical industry, nutraceutical industry, cosmetic industry, research laboratories) and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of the empty capsules market. A thorough analysis of key industry players has been conducted to provide insights into their business overview, products, and key strategies, including new product launches, collaborations, and partnership agreements. Key Benefits of Buying the Report: The report will assist market leaders and new entrants by providing close estimates of revenue in the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to more effectively position their businesses and develop appropriate go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on the key drivers, restraints, opportunities, and challenges within the market. The report provides insights on the following pointers: • Analysis of key drivers (growth in nutraceuticals & personalized supplements market, growing focus on pharmaceutical development and subsequent increase in clinical trials, expansion of functional & modified-release capsules, sustainability & regulatory-driven transition, increasing preference for self-medication and OTC drugs, shift toward vegetarian & clean-label capsules) restraints (dietary restrictions associated with gelatin consumption, issues related to safety and efficacy, competition from other drug delivery technologies), opportunities (geographic expansion & localized production in emerging economies, development of biodegradable and sustainable capsules), and challenges (challenges associated with logistics and storage of empty capsules, raw material availability & supply chain dependence) • Product Development/Innovation: Detailed insights on upcoming products, technologies, research & development activities in the empty capsules market • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions. • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the empty capsules market • Competitive Assessment: In-depth assessment of market shares, company revenue, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/approvals, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the empty capsules market.
目錄 Table of Contents
1 INTRODUCTION 41 1.1 STUDY OBJECTIVES 41 1.2 MARKET DEFINITION 41 1.3 STUDY SCOPE 42 1.3.1 EMPTY CAPSULES MARKET SEGMENTATION & REGIONAL SCOPE 42 1.3.2 INCLUSIONS & EXCLUSIONS 43 1.3.3 YEARS CONSIDERED 43 1.3.4 UNITS CONSIDERED 44 1.3.4.1 Currency/Value units 44 1.3.4.2 Volume units 44 1.4 STAKEHOLDERS 44 1.5 SUMMARY OF CHANGES 44 2 RESEARCH METHODOLOGY 46 2.1 RESEARCH APPROACH 46 2.1.1 SECONDARY DATA 47 2.1.1.1 Key sources of secondary data 47 2.1.1.2 Key objectives of secondary research 47 2.1.2 PRIMARY DATA 48 2.1.2.1 Breakdown of primaries 48 2.1.2.2 Key objectives of primary research 48 2.2 MARKET ESTIMATION METHODOLOGY 49 2.2.1 GLOBAL EMPTY CAPSULES MARKET ESTIMATION, 2024 49 2.2.1.1 Company revenue analysis (bottom-up approach) 49 2.2.1.2 Volume-based estimation 50 2.2.1.3 MNM repository analysis 52 2.2.1.4 Primary research 52 2.2.2 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH) 53 2.3 MARKET GROWTH RATE PROJECTIONS 54 2.4 DATA TRIANGULATION 57 2.5 STUDY ASSUMPTIONS 58 2.6 RESEARCH LIMITATIONS 59 2.7 RISK ANALYSIS 59 3 EXECUTIVE SUMMARY 60 3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 60 3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS IN EMPTY CAPSULES MARKET 66 3.3 DISRUPTIVE TRENDS SHAPING EMPTY CAPSULES MARKET 67 4 PREMIUM INSIGHTS 68 4.1 SNAPSHOT: GLOBAL EMPTY CAPSULES MARKET, CAGR, AND FORECAST (2025–2030) 68 4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2024) 69 4.3 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION (2024) 69 4.4 EMPTY CAPSULES MARKET, BY END USER (2024) 70 4.5 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70 5 MARKET OVERVIEW 71 5.1 INTRODUCTION 71 5.2 MARKET DYNAMICS 71 5.2.1 DRIVERS 73 5.2.1.1 Increasing demand for nutraceuticals and personalized supplements 73 5.2.1.2 Growing focus on pharmaceutical development and increase in clinical trials 73 5.2.1.3 Increased demand for functional and modified-release capsules in pharmaceutical and nutraceutical industries 75 5.2.1.4 Advancements in capsule delivery technologies 75 5.2.1.5 Shift toward vegetarian, vegan, and clean-label capsules 76 5.2.1.6 Growing preference for self-medication and OTC drugs 76 5.2.2 RESTRAINTS 77 5.2.2.1 Dietary restrictions associated with gelatin consumption 77 5.2.2.2 Issues related to safety and efficacy of gelatin capsules 77 5.2.2.3 Competition from alternative drug delivery technologies 78 5.2.3 OPPORTUNITIES 78 5.2.3.1 Geographic expansion and localized production in emerging economies 78 5.2.3.2 Development of biodegradable and sustainable capsules in life sciences industry 79 5.2.4 CHALLENGES 79 5.2.4.1 Challenges associated with logistics and storage of empty capsules 79 5.2.4.2 Lack of adequate raw material and increased supply chain dependence 80 5.3 INDUSTRY TRENDS 80 5.3.1 AI-INTEGRATED AND PERSONALIZED DRUG AND SUPPLEMENT FORMULATION AND DOSING 80 5.3.2 ON-DEMAND MANUFACTURING SYSTEMS AND DECENTRALIZED CAPSULE-BASED FORMULATIONS IN CLINICAL TRIALS 80 5.3.3 INTEGRATION OF SMART CAPSULES AND INGESTIBLE SENSORS IN CLINICAL RESEARCH 81 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81 5.5 PRICING ANALYSIS 82 5.5.1 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE, 2022−2024 82 5.5.2 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2022−2024 83 5.5.3 FACTORS IMPACTING EMPTY CAPSULES PRICING 84 5.6 TECHNOLOGY ANALYSIS 85 5.6.1 KEY TECHNOLOGIES 85 5.6.1.1 Advanced quality control systems 85 5.6.1.2 Automated encapsulation machines 85 5.6.2 COMPLEMENTARY TECHNOLOGIES 86 5.6.2.1 3D printing 86 5.6.2.2 Enteric capsule technologies 86 5.6.3 ADJACENT TECHNOLOGIES 86 5.6.3.1 Nanotechnology 86 5.6.3.2 AI in capsule manufacturing 87 5.7 VALUE CHAIN ANALYSIS 87 5.8 ECOSYSTEM ANALYSIS 89 5.8.1 RAW MATERIAL VENDORS 89 5.8.2 PRODUCT PROVIDERS 90 5.8.3 END USERS 90 5.8.4 REGULATORY AUTHORITIES 91 5.8.5 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT 91 5.9 PORTER’S FIVE FORCES ANALYSIS 93 5.9.1 THREAT OF NEW ENTRANTS 94 5.9.2 THREAT OF SUBSTITUTES 94 5.9.3 BARGAINING POWER OF SUPPLIERS 94 5.9.4 BARGAINING POWER OF BUYERS 94 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 95 5.10 KEY STAKEHOLDERS & BUYING CRITERIA 95 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 95 5.10.2 KEY BUYING CRITERIA 97 5.10.3 ADOPTION BARRIER & INTERNAL FRICTION 99 5.11 PATENT ANALYSIS 99 5.11.1 PATENT METHODOLOGY 99 5.11.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 99 5.11.3 INNOVATION & PATENT APPLICATIONS 100 5.11.4 TOP APPLICANTS 100 5.11.5 INDICATIVE LIST OF PATENTS 101 5.12 KEY CONFERENCES & EVENTS, 2025–2026 103 5.13 TRADE ANALYSIS 104 5.13.1 IMPORT AND EXPORT DATA FOR HS CODE 960200 104 5.13.1.1 Import data for HS code 960200, 2020−2024 104 5.13.1.2 Export data for HS code 960200, 2020−2024 105 5.13.2 IMPORT AND EXPORT VOLUME FOR HS CODE 960200 106 5.13.2.1 Import volume for HS code 960200, 2020–2024 106 5.13.2.2 Export volume for HS code 960200, 2020–2024 107 5.14 TARRIF DATA & REGULATORY ANALYSIS 108 5.14.1 TARIFF DATA ANALYSIS 108 5.14.2 REGULATORY FRAMEWORK 108 5.14.2.1 Manufacturing process standards 108 5.14.2.2 Regulations for capsule supplier change 110 5.14.2.3 Regulatory information on colorants 110 5.14.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 5.14.4 REGULATORY CHALLENGES 114 5.14.5 SUSTAINABILITY IMPACT 115 5.15 CUSTOMER LANDSCAPE 116 5.15.1 UNMET NEEDS & WHITE SPACES 116 5.15.2 CAPSULE PURCHASE/PROCUREMENT MODELS 116 5.15.3 BUDGET ALLOCATION TREND 116 5.15.4 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES 117 5.16 INVESTMENT & FUNDING SCENARIO 118 5.17 IMPACT OF AI/GEN AI ON EMPTY CAPSULES MARKET 120 5.17.1 MARKET POTENTIAL OF AI IN EMPTY CAPSULES PRODUCTION 120 5.17.2 AI USE CASES 121 5.17.3 KEY COMPANIES IMPLEMENTING AI 121 5.17.4 FUTURE OF GENERATIVE AI IN EMPTY CAPSULES ECOSYSTEM 122 5.18 IMPACT OF 2025 TRUMP TARIFF ON EMPTY CAPSULES MARKET 122 5.18.1 INTRODUCTION 122 5.18.2 KEY TARIFF RATES 123 5.18.3 PRICE IMPACT ANALYSIS 124 5.18.4 IMPACT ON COUNTRY/REGION 124 5.18.4.1 North America 124 5.18.4.1.1 US 124 5.18.4.2 Europe 124 5.18.4.3 Asia Pacific 125 5.18.5 IMPACT ON END-USE INDUSTRIES 125 5.18.5.1 Pharmaceutical & biotech companies 125 5.18.5.2 Nutraceutical industry 126 5.18.5.3 Cosmetic industry 126 5.19 EMPTY CAPSULES MANUFACTURING PROCESS 126 5.19.1 SOURCING OF RAW MATERIAL 126 5.19.1.1 Identify source 126 5.19.1.2 Impact of source variation on product quality 127 5.19.1.3 Certification for sustainable and ethical sourcing 127 5.19.1.4 Impact of market dynamics on raw material sourcing 127 5.19.1.5 Role of industry associations on raw material sourcing 127   5.19.2 PROCESSING 128 5.19.3 QUALITY CONTROL & PACKAGING 128 5.20 EMPTY CAPSULES PRODUCTION CAPACITY 129 5.21 INTERCONNECTED MARKET: INSIGHTS ON PHARMACEUTICAL GELATIN MARKET 130 6 EMPTY CAPSULES MARKET, BY TYPE 131 6.1 INTRODUCTION 132 6.2 GELATIN CAPSULES 132 6.2.1 PROVEN SAFETY, VERSATILITY, EASE OF MANUFACTURING, QUICK DISINTEGRATION, AND HIGH BIOAVAILABILITY TO DRIVE ADOPTION 132 6.2.2 GELATIN EMPTY CAPSULES VOLUME MARKET, BY REGION 136 6.3 NON-GELATIN CAPSULES 137 6.3.1 SHIFT OF CONSUMER DEMAND TOWARD CLEAN-LABEL, VEGAN, AND SUSTAINABLE SOLUTIONS TO PROPEL MARKET GROWTH 137 6.3.2 NON-GELATIN EMPTY CAPSULES VOLUME MARKET, BY REGION 141 7 EMPTY CAPSULES MARKET, BY RAW MATERIAL 142 7.1 INTRODUCTION 143 7.2 GELATIN CAPSULES MARKET, BY RAW MATERIAL 143 7.2.1 PORCINE GELATIN 143 7.2.1.1 Cost-effectiveness, high availability, and quick dissolving properties to support use in hard capsule production 143 7.2.2 BOVINE-DERIVED GELATIN 147 7.2.2.1 Reduced cattle slaughter to limit market growth 147 7.2.3 BONEMEAL GELATIN 150 7.2.3.1 Rising demand for bonemeal capsules in pharmaceutical industry to encourage market growth 150 7.2.4 OTHER GELATIN SOURCES 154 7.3 NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL 157 7.3.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC) 157 7.3.1.1 Chemical & thermal stability, faster dissolution, and low brittleness in low humidity to favor market growth 157 7.3.2 PULLULAN & STARCH 161 7.3.2.1 Increasing demand for transparent, vegan, and non-GMO capsules to accelerate market growth 161 8 EMPTY CAPSULES MARKET, BY FUNCTIONALITY 165 8.1 INTRODUCTION 166 8.2 IMMEDIATE-RELEASE CAPSULES 166 8.2.1 RAPID ABSORPTION, LOW PRODUCTION COST, AND BROAD APPLICATIONS TO AUGMENT MARKET GROWTH 166 8.3 SUSTAINED-RELEASE CAPSULES 170 8.3.1 CONTROLLED DRUG RELEASE FOR CHRONIC DISEASE MANAGEMENT TO SPUR MARKET GROWTH 170   8.4 DELAYED-RELEASE CAPSULES 173 8.4.1 DEMAND FOR ENTERIC-COATED CAPSULES AND ADVANCEMENTS IN PH-SENSITIVE POLYMER COATINGS TO DRIVE MARKET 173 9 EMPTY CAPULES MARKET, BY SIZE 177 9.1 INTRODUCTION 178 9.2 SIZE 0 178 9.2.1 RISING DEMAND FOR MID-DOSE FORMULATIONS TO FUEL MAKET GROWTH 178 9.3 SIZE 00 182 9.3.1 INCREASED NEED FOR ENCAPSULATING SINGLE-DOSE HERBAL EXTRACTS TO BOOST MARKET GROWTH 182 9.4 SIZE 1 185 9.4.1 NEED FOR COMPACT, LOW-TO-MID DOSE FORMULATIONS WITH HIGH SWALLOWABILITY TO BOOST ADOPTION 185 9.5 SIZE 2 189 9.5.1 DOSE ACCURACY, COMPATIBILITY WITH DIETARY PREFERENCES, AND STANDARD MANUFACTURING EQUIPMENT TO SPUR MARKET 189 9.6 SIZE 000 192 9.6.1 POPULARITY OF HIGH-DOSE CAPSULES IN SPORTS NUTRITION, FUNCTIONAL MEDICINES, AND HERBAL FORMULATIONS TO DRIVE MARKET 192 9.7 SIZE 3 196 9.7.1 NEED FOR PRECISE AND LOW-DOSE DELIVERY TO AUGMENT MARKET GROWTH 196 9.8 SIZE 4 199 9.8.1 FOCUS ON DOSE PERSONALIZATION AND PATIENT-CENTRIC CARE TO FUEL ADOPTION IN PEDIATRIC DOSING AND GERIATRIC MEDICATIONS 199 9.9 SIZE 5 202 9.9.1 MINIMAL CAPACITY AND SMALL FOOTPRINT TO BE USEFUL IN SPECIALTY SEGMENTS 202 10 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION 205 10.1 INTRODUCTION 206 10.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS 206 10.2.1 HIGH INCIDENCE OF INFECTIOUS DISEASES AND FOCUS ON INNOVATIVE CAPSULE FORMULATIONS TO DRIVE MARKET 206 10.3 DIETARY SUPPLEMENTS 210 10.3.1 HIGH UPTAKE OF MULTIVITAMINS TO BOOST MARKET DEMAND 210 10.4 ANTACID & ANTIFLATULENT PREPARATIONS 213 10.4.1 POPULARITY OF GENERIC MEDICATIONS AND LIFESTYLE CHANGES IN EMERGING ECONOMIES TO SPUR MARKET GROWTH 213 10.5 ANTIANEMIC PREPARATIONS 217 10.5.1 RISING PREVALENCE OF ANEMIA TO SUPPORT MARKET FOR IRON & FOLIC ACID DEFICIENCY CAPSULES 217 10.6 ANTI-INFLAMMATORY DRUGS 220 10.6.1 EXPANSION OF GENERIC THERAPEUTICS MARKET FOR OBESITY TO PROPEL MARKET GROWTH 220 10.7 CARDIOVASCULAR THERAPY DRUGS 223 10.7.1 SEDENTARY LIFESTYLE AND HIGH PREVALENCE OF DIABETES TO BOOST MARKET GROWTH 223 10.8 COUGH & COLD DRUGS 227 10.8.1 RISING ENVIRONMENTAL POLLUTION AND INCREASING NUMBER OF PASSIVE SMOKERS TO FAVOR MARKET GROWTH 227 10.9 OTHER THERAPEUTIC APPLICATIONS 230 11 EMPTY CAPSULES MARKET, BY END USER 234 11.1 INTRODUCTION 235 11.2 PHARMACEUTICAL INDUSTRY 235 11.2.1 INCREASING FOCUS ON ADVANCED DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET GROWTH 235 11.3 NUTRACEUTICAL INDUSTRY 239 11.3.1 GROWING DEMAND FOR DIETARY SUPPLEMENTS TO BOOST MARKET DEMAND 239 11.4 COSMETIC INDUSTRY 243 11.4.1 RISING FOCUS ON PERSONALIZED BEAUTY AND HOLISTIC WELLNESS TO SUPPORT MARKET GROWTH 243 11.5 RESEARCH LABORATORIES 246 11.5.1 GROWING FOCUS ON CLINICAL TRIALS TO SUPPORT ADOPTION IN PRECISE DOSING AND PHARMACEUTICAL TESTING 246 12 EMPTY CAPSULES MARKET, BY REGION 250 12.1 INTRODUCTION 251 12.1.1 GLOBAL EMPTY CAPSULES MARKET VOLUME 251 12.2 NORTH AMERICA 252 12.2.1 NORTH AMERICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE 253 12.2.2 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 254 12.2.3 US 258 12.2.3.1 US to dominate North American empty capsules market during forecast period 258 12.2.4 CANADA 262 12.2.4.1 Rising per capita healthcare spending and growing elderly population to propel market growth 262 12.3 EUROPE 266 12.3.1 EUROPEAN EMPTY CAPSULES VOLUME MARKET, BY TYPE 267 12.3.2 MACROECONOMIC OUTLOOK FOR EUROPE 267 12.3.3 GERMANY 272 12.3.3.1 Rising consumer demand for capsule-based pharma and nutraceutical formulations to aid market growth 272 12.3.4 UK 275 12.3.4.1 High demand for nutraceuticals and rapid shift toward plant-based lifestyles to augment market growth 275   12.3.5 FRANCE 279 12.3.5.1 Popularity of self-care trends and regulatory push for plant-based capsules to propel market growth 279 12.3.6 ITALY 282 12.3.6.1 High R&D spending in pharmaceutical manufacturing industry to support market growth 282 12.3.7 SPAIN 286 12.3.7.1 Low production costs and consolidation of biotechnology sector to fuel market growth 286 12.3.8 NETHERLANDS 289 12.3.8.1 Expanding clinical research activity and strong nutraceutical innovation ecosystem to drive market 289 12.3.9 REST OF EUROPE 292 12.4 ASIA PACIFIC 295 12.4.1 ASIA PACIFIC EMPTY CAPSULES VOLUME MARKET, BY TYPE 296 12.4.2 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 297 12.4.3 CHINA 301 12.4.3.1 Rapidly growing pharmaceutical, cosmetic, and nutraceutical industries to augment market growth 301 12.4.4 INDIA 305 12.4.4.1 Surge in demand for dietary supplements and presence of highly skilled medical professionals to favor market growth 305 12.4.5 JAPAN 308 12.4.5.1 Increased demand for high-quality generic oral drugs to boost market demand 308 12.4.6 SOUTH KOREA 312 12.4.6.1 Increased government focus on domestic drug production and R&D to support market growth 312 12.4.7 AUSTRALIA 315 12.4.7.1 Rising incidence of chronic diseases among geriatric population and increasing demand for supplements to fuel market growth 315 12.4.8 NEW ZEALAND 318 12.4.8.1 Increasing prevalence of lifestyle-related disorders and expanding therapeutic supplement use to propel market growth 318 12.4.9 REST OF ASIA PACIFIC 322 12.5 LATIN AMERICA 325 12.5.1 LATIN AMERICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE 325 12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 326 12.5.3 BRAZIL 330 12.5.3.1 High export of generics to support market growth 330 12.5.4 MEXICO 333 12.5.4.1 Well-developed healthcare regulatory environment and increased demand for chronic disease treatment to favor market growth 333 12.5.5 REST OF LATIN AMERICA 336   12.6 MIDDLE EAST 339 12.6.1 MIDDLE EASTERN EMPTY CAPSULES VOLUME MARKET, BY TYPE 339 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 340 12.6.3 GCC COUNTRIES 344 12.6.3.1 Saudi Arabia 348 12.6.3.1.1 Favorable government-led healthcare reforms and increased pharmaceutical production capabilities to aid market growth 348 12.6.3.2 UAE 351 12.6.3.2.1 Favorable government strategies and high per capita health expenditure to fuel market growth 351 12.6.3.3 Rest of GCC Countries 354 12.6.4 REST OF MIDDLE EAST 357 12.7 AFRICA 360 12.7.1 DEVELOPMENT OF PHARMACEUTICAL SECTOR TO SPUR MARKET GROWTH 360 12.7.2 AFRICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE 360 12.7.3 MACROECONOMIC OUTLOOK FOR AFRICA 361 13 COMPETITIVE LANDSCAPE 365 13.1 INTRODUCTION 365 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 365 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EMPTY CAPSULES MARKET, JANUARY 2022–JULY 2025 365 13.3 REVENUE ANALYSIS, 2020–2024 366 13.4 MARKET SHARE ANALYSIS, 2024 367 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 369 13.5.1 STARS 369 13.5.2 EMERGING LEADERS 370 13.5.3 PERVASIVE PLAYERS 370 13.5.4 PARTICIPANTS 370 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 372 13.5.5.1 Company footprint 372 13.5.5.2 Region footprint 373 13.5.5.3 Type footprint 374 13.5.5.4 Functionality footprint 375 13.5.5.5 End-user footprint 376 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 377 13.6.1 PROGRESSIVE COMPANIES 377 13.6.2 RESPONSIVE COMPANIES 377 13.6.3 DYNAMIC COMPANIES 377 13.6.4 STARTING BLOCKS 378 13.6.5 COMPETITIVE BENCHMARKING 379 13.6.5.1 Detailed list of key startups/SMEs 379 13.6.5.2 Competitive benchmarking of startups/SMEs 380 13.7 COMPANY VALUATION & FINANCIAL METRICS 381 13.7.1 FINANCIAL METRICS 381 13.7.2 COMPANY VALUATION 381 13.8 BRAND/PRODUCT COMPARISON 382 13.9 COMPETITIVE SCENARIO 383 13.9.1 PRODUCT LAUNCHES & APPROVALS 383 13.9.2 DEALS 384 13.9.3 EXPANSIONS 385 13.9.4 OTHER DEVELOPMENTS 386 14 COMPANY PROFILES 387 14.1 KEY PLAYERS 387 14.1.1 CAPSUGEL (LONZA) 387 14.1.1.1 Business overview 387 14.1.1.2 Products offered 388 14.1.1.3 Recent developments 390 14.1.1.3.1 Product launches 390 14.1.1.3.2 Other developments 391 14.1.1.4 MnM view 391 14.1.1.4.1 Key strengths 391 14.1.1.4.2 Strategic choices 391 14.1.1.4.3 Weaknesses & competitive threats 391 14.1.2 ACG 392 14.1.2.1 Business overview 392 14.1.2.2 Products offered 393 14.1.2.3 Recent developments 394 14.1.2.3.1 Expansions 394 14.1.2.3.2 Other developments 394 14.1.2.4 MnM view 395 14.1.2.4.1 Key strengths 395 14.1.2.4.2 Strategic choices 395 14.1.2.4.3 Weaknesses & competitive threats 395 14.1.3 QUALICAPS (ROQUETTE FRÈRES) 396 14.1.3.1 Business overview 396 14.1.3.2 Products offered 397 14.1.3.3 Recent developments 398 14.1.3.3.1 Deals 398 14.1.3.3.2 Expansions 399   14.1.3.4 MnM view 399 14.1.3.4.1 Key strengths 399 14.1.3.4.2 Strategic choices 399 14.1.3.4.3 Weaknesses & competitive threats 399 14.1.4 SUHEUNG 400 14.1.4.1 Business overview 400 14.1.4.2 Products offered 401 14.1.4.3 Recent developments 402 14.1.4.3.1 Product launches & approvals 402 14.1.5 HEALTHCAPS INDIA 404 14.1.5.1 Business overview 404 14.1.5.2 Products offered 405 14.1.6 NECTAR LIFESCIENCES LTD. 406 14.1.6.1 Business overview 406 14.1.6.2 Products offered 407 14.1.6.3 Recent developments 407 14.1.6.3.1 Deals 407 14.1.7 SUNIL HEALTHCARE LIMITED 408 14.1.7.1 Business overview 408 14.1.7.2 Products offered 409 14.1.8 NATURAL CAPSULES LIMITED 411 14.1.8.1 Business overview 411 14.1.8.2 Products offered 412 14.1.8.3 Recent developments 413 14.1.8.3.1 Deals 413 14.1.9 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.) 414 14.1.9.1 Business overview 414 14.1.9.2 Products offered 415 14.1.9.3 Recent developments 415 14.1.9.3.1 Product launches 415 14.1.10 COMED CHEMICALS LIMITED 416 14.1.10.1 Business overview 416 14.1.10.2 Products offered 417 14.1.11 ANHUI HUANGSHAN CAPSULE CO., LTD. 418 14.1.11.1 Business overview 418 14.1.11.2 Products offered 419 14.1.12 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED) 420 14.1.12.1 Business overview 420 14.1.12.2 Products offered 421 14.1.12.3 Recent developments 421 14.1.12.3.1 Deals 421 14.1.13 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.) 422 14.1.13.1 Business overview 422 14.1.13.2 Products offered 423 14.1.14 CAPSCANADA 424 14.1.14.1 Business overview 424 14.1.14.2 Products offered 424 14.1.15 FARMACÁPSULAS 426 14.1.15.1 Business overview 426 14.1.15.2 Products offered 426 14.1.16 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD. 428 14.1.16.1 Business overview 428 14.1.16.2 Products offered 428 14.1.16.3 Recent developments 429 14.1.16.3.1 Other developments 429 14.1.17 ERAWAT PHARMA LIMITED 430 14.1.17.1 Business overview 430 14.1.17.2 Products offered 430 14.2 OTHER PLAYERS 432 14.2.1 SAVIOURCAPS 432 14.2.2 SHANXI JC BIOLOGICAL TECHNOLOGY CO. 433 14.2.3 ROXLOR 433 14.2.4 MEDISCA INC. 434 14.2.5 ZHEJIANG YUEXI CAPSULE CO., LTD. 435 14.2.6 SHAOXING KANGKE CAPSULE CO., LTD. 436 14.2.7 ZHEJIANG HUILI CAPSULES CO., LTD. 437 14.2.8 SHAOXING ZHONGYA CAPSULE CO., LTD. 438 14.2.9 SHING LIH FANG ENTERPRISE CO., LTD. 439 14.2.10 LEFANCAPS 440 14.2.11 CHEMCAPS LIMITED 441 14.2.12 BIOCAPS ENTERPRISE 441 14.2.13 SNAIL PHARMA INDUSTRY 442 14.2.14 BRIGHT PHARMA CAPS 443 14.2.15 SHREE PHARMA CAPS 444 14.2.16 HEXIN CAPSULE CO., LTD. 445 14.2.17 WUHAN CARMA TECHNOLOGY CO., LTD. 446 14.2.18 AIPAK PHARMA 447   15 APPENDIX 448 15.1 DISCUSSION GUIDE 448 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 455 15.3 CUSTOMIZATION OPTIONS 457 15.4 RELATED REPORTS 458 15.5 AUTHOR DETAILS 459
圖表清單 List of Tables & Figures
TABLE 1 EMPTY CAPSULES MARKET: INCLUSIONS & EXCLUSIONS 43 TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 55 TABLE 3 EMPTY CAPSULES MARKET: RISK ANALYSIS 59 TABLE 4 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 72 TABLE 5 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE, 2022−2024 (USD) 82 TABLE 6 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2022−2024 (USD) 83 TABLE 7 EMPTY CAPSULES MARKET: RAW MATERIAL VENDORS 89 TABLE 8 EMPTY CAPSULES MARKET: PRODUCT PROVIDERS 90 TABLE 9 EMPTY CAPSULES MARKET: END USERS 91 TABLE 10 EMPTY CAPSULES MARKET: REGULATORY AUTHORITIES 91 TABLE 11 EMERGING BUSINESS MODELS AND TARGET SEGMENTS IN EMPTY CAPSULES MARKET 92 TABLE 12 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES 93 TABLE 13 KEY STAKEHOLDERS ACROSS VARIOUS END-USE INDUSTRIES INFLUENCING BUYING PROCESS 96 TABLE 14 KEY BUYING CRITERIA FOR EMPTY CAPSULES, BY END USER 97 TABLE 15 EMPTY CAPSULES: ADOPTION BARRIER & INTERNAL FRICTION 99 TABLE 16 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014−2024 99 TABLE 17 TOP 10 PATENT OWNERS/APPLICANTS IN EMPTY CAPSULES MARKET, 2014−2024 101 TABLE 18 INDICATIVE LIST OF PATENTS IN EMPTY CAPSULES MARKET, 2023−2025 101 TABLE 19 EMPTY CAPSULES MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026 103 TABLE 20 IMPORT DATA FOR HS CODE 960200, 2020−2024 (USD THOUSAND) 104 TABLE 21 EXPORT DATA FOR HS CODE 960200, 2020−2024 (USD THOUSAND) 105 TABLE 22 IMPORT VOLUME FOR HS CODE 960200, 2020–2024 (TONS) 106 TABLE 23 EXPORT VOLUME FOR HS CODE 960200, 2020–2024 (TONS) 107 TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114 TABLE 28 STARTEGIC ANALYSIS OF GROWTH OPPORTUNITIES IN EMPTY CAPSULES MARKET 117 TABLE 29 KEY COMPANIES IMPLEMENTING AI IN EMPTY CAPSULES MARKET 121 TABLE 30 EMPTY CAPSULES-RELATED TARIFF REVISION 123 TABLE 31 KEY PLAYERS AND THEIR INSTALLED ANNUAL PRODUCTION CAPACITY IN EMPTY CAPSULES MARKET 129 TABLE 32 EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 132 TABLE 33 EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS) 132 TABLE 34 GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 35 NORTH AMERICA: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 36 EUROPE: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 37 ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 38 LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 39 MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 40 GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 41 GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (BILLION UNITS) 137 TABLE 42 NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 43 NORTH AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 44 EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 45 ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 46 LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 47 MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 48 GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 49 NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (BILLION UNITS) 141 TABLE 50 GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 143 TABLE 51 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 52 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 53 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 54 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 55 LATIN AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 56 MIDDLE EAST: PORCINE GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 57 GCC COUNTRIES: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 58 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 59 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 60 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 61 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 62 LATIN AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 63 MIDDLE EAST: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 64 GCC COUNTRIES: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 65 BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 66 NORTH AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 67 EUROPE: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 68 ASIA PACIFIC: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 69 LATIN AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 70 MIDDLE EAST: BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 71 GCC COUNTRIES: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 72 OTHER GELATIN SOURCES MARKET, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 73 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 74 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 75 ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 76 LATIN AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 77 MIDDLE EAST: OTHER GELATIN SOURCES MARKET, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 78 GCC COUNTRIES: OTHER GELATIN CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 79 NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 157 TABLE 80 HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 81 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 82 EUROPE: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 83 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 84 LATIN AMERICA: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 85 MIDDLE EAST: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 86 GCC COUNTRIES: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 87 PULLULAN & STARCH MARKET, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 88 NORTH AMERICA: PULLULAN & STARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 89 EUROPE: PULLULAN & STARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 90 ASIA PACIFIC: PULLULAN & STARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 91 LATIN AMERICA: PULLULAN & STARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 92 MIDDLE EAST: PULLULAN & STARCH MARKET, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 93 GCC COUNTRIES: PULLULAN & STARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 94 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 166 TABLE 95 IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 96 NORTH AMERICA: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 97 EUROPE: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 98 ASIA PACIFIC: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 99 LATIN AMERICA: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 100 MIDDLE EAST: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 101 GCC COUNTRIES: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 102 SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 103 NORTH AMERICA: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 104 EUROPE: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 105 ASIA PACIFIC: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 106 LATIN AMERICA: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 107 MIDDLE EAST: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 108 GCC COUNTRIES: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 109 DELAYED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 174 TABLE 110 NORTH AMERICA: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 111 EUROPE: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 112 ASIA PACIFIC: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 113 LATIN AMERICA: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 114 MIDDLE EAST: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 115 GCC COUNTRIES: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 116 EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 178 TABLE 117 SIZE 0 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 118 NORTH AMERICA: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 119 EUROPE: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 120 ASIA PACIFIC: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 121 LATIN AMERICA: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 122 MIDDLE EAST: SIZE 0 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 181 TABLE 123 GCC COUNTRIES: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 124 SIZE 00 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 125 NORTH AMERICA: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 126 EUROPE: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 127 ASIA PACIFIC: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 128 LATIN AMERICA: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 129 MIDDLE EAST: SIZE 00 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 130 GCC COUNTRIES: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 131 SIZE 1 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 186 TABLE 132 NORTH AMERICA: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 133 EUROPE: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 134 ASIA PACIFIC: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 135 LATIN AMERICA: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 136 MIDDLE EAST: SIZE 1 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 188 TABLE 137 GCC COUNTRIES: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 138 SIZE 2 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 139 NORTH AMERICA: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 140 EUROPE: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 141 ASIA PACIFIC: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 142 LATIN AMERICA: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 143 MIDDLE EAST: SIZE 2 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 144 GCC COUNTRIES: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 145 SIZE 000 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 193 TABLE 146 NORTH AMERICA: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 147 EUROPE: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 148 ASIA PACIFIC: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 149 LATIN AMERICA: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 150 MIDDLE EAST: SIZE 000 EMPTY CAPSULES MARKET, BY REGION 2023–2030 (USD MILLION) 195 TABLE 151 GCC COUNTRIES: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 152 SIZE 3 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 196 TABLE 153 NORTH AMERICA: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 154 EUROPE: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 155 ASIA PACIFIC: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 156 LATIN AMERICA: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 157 MIDDLE EAST: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 158 GCC COUNTRIES: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 159 SIZE 4 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 199 TABLE 160 NORTH AMERICA: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 161 EUROPE: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 162 ASIA PACIFIC: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 163 LATIN AMERICA: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 164 MIDDLE EAST: SIZE 4 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 165 GCC COUNTRIES: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 166 SIZE 5 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 202 TABLE 167 NORTH AMERICA: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 168 EUROPE: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 169 ASIA PACIFIC: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 170 LATIN AMERICA: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 171 MIDDLE EAST: SIZE 5 EMPTY Y CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 204 TABLE 172 GCC COUNTRIES: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 173 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 206 TABLE 174 EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2023–2030 (USD MILLION) 207 TABLE 175 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 176 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 177 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 178 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 179 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2023–2030 (USD MILLION) 209 TABLE 180 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 181 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2023–2030 (USD MILLION) 210 TABLE 182 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 183 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 184 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 185 LATIN AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 186 MIDDLE EAST: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2023–2030 (USD MILLION) 213 TABLE 187 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 188 EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2023–2030 (USD MILLION) 214 TABLE 189 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 190 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 191 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 192 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 193 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2023–2030 (USD MILLION) 216 TABLE 194 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 195 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2023–2030 (USD MILLION) 217 TABLE 196 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 197 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 198 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 199 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 200 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2023–2030 (USD MILLION) 219 TABLE 201 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 202 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2023–2030 (USD MILLION) 220 TABLE 203 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 204 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 205 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 206 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 207 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2023–2030 (USD MILLION) 223 TABLE 208 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 209 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2023–2030 (USD MILLION) 224 TABLE 210 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 211 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 212 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 213 LATIN AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 214 MIDDLE EAST: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2023–2030 (USD MILLION) 226 TABLE 215 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 216 EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION, 2023–2030 (USD MILLION) 227 TABLE 217 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 218 EUROPE: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 219 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 220 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 221 MIDDLE EAST: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION, 2023–2030 (USD MILLION) 230 TABLE 222 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 223 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 231 TABLE 224 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 225 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 226 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 227 LATIN AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 228 MIDDLE EAST: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 233 TABLE 229 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 230 EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 235 TABLE 231 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 236 TABLE 232 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 233 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 234 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 235 LATIN AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 236 MIDDLE EAST: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 238 TABLE 237 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 238 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 240 TABLE 239 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 240 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 241 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 242 LATIN AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 243 MIDDLE EAST: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 242 TABLE 244 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 245 EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 243 TABLE 246 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 247 EUROPE: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 248 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 249 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 250 MIDDLE EAST: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 246 TABLE 251 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 252 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 247 TABLE 253 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 254 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 255 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 256 LATIN AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 257 MIDDLE EAST: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 249 TABLE 258 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 259 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 251 TABLE 260 EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (BILLION UNITS) 252 TABLE 261 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS) 254 TABLE 262 NORTH AMERICA: KEY MACROINDICATORS 255 TABLE 263 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 264 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 265 NORTH AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 256 TABLE 266 NORTH AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 256 TABLE 267 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 256 TABLE 268 NORTH AMERICA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 257 TABLE 269 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 257 TABLE 270 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 258 TABLE 271 US: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 272 US: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 259 TABLE 273 US: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 260 TABLE 274 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 260 TABLE 275 US: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 261 TABLE 276 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 261 TABLE 277 US: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 278 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 279 CANADA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 263 TABLE 280 CANADA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 263 TABLE 281 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 264 TABLE 282 CANADA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 264 TABLE 283 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 265 TABLE 284 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 265 TABLE 285 COMPARATIVE ANALYSIS OF GENERIC PENETRATION AMONG EUROPEAN COUNTRIES, BY VOLUME, 2025 266 TABLE 286 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS) 267 TABLE 287 EUROPE: KEY MACROINDICATORS 268 TABLE 288 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 289 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 290 EUROPE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 269 TABLE 291 EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 269 TABLE 292 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 270 TABLE 293 EUROPE: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 270 TABLE 294 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 271 TABLE 295 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 271 TABLE 296 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 297 GERMANY: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 273 TABLE 298 GERMANY: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 273 TABLE 299 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 273 TABLE 300 GERMANY: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 274 TABLE 301 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 274 TABLE 302 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 275 TABLE 303 UK: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 304 UK: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 276 TABLE 305 UK: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 276 TABLE 306 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 277 TABLE 307 UK: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 277 TABLE 308 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 278 TABLE 309 UK: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 278 TABLE 310 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 311 FRANCE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 279 TABLE 312 FRANCE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 280 TABLE 313 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 280 TABLE 314 FRANCE: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 281 TABLE 315 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 281 TABLE 316 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 282 TABLE 317 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 318 ITALY: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 283 TABLE 319 ITALY: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 283 TABLE 320 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 284 TABLE 321 ITALY: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 284 TABLE 322 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 285 TABLE 323 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 324 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 325 SPAIN: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 286 TABLE 326 SPAIN: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 287 TABLE 327 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 287 TABLE 328 SPAIN: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 288 TABLE 329 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 288 TABLE 330 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 331 NETHERLANDS: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 332 NETHERLANDS: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 290 TABLE 333 NETHERLANDS: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 290 TABLE 334 NETHERLANDS: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 290 TABLE 335 NETHERLANDS: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 291 TABLE 336 NETHERLANDS: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 291 TABLE 337 NETHERLANDS: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 292 TABLE 338 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 339 REST OF EUROPE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 293 TABLE 340 REST OF EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 293 TABLE 341 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 293 TABLE 342 REST OF EUROPE: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 294 TABLE 343 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 294 TABLE 344 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 295 TABLE 345 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS) 297 TABLE 346 ASIA PACIFIC: KEY MACROINDICATORS 297 TABLE 347 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 298 TABLE 348 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 349 ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 299 TABLE 350 ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 299 TABLE 351 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 299 TABLE 352 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 300 TABLE 353 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 300 TABLE 354 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 301 TABLE 355 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 356 CHINA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 302 TABLE 357 CHINA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 302 TABLE 358 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 303 TABLE 359 CHINA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 303 TABLE 360 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 304 TABLE 361 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 304 TABLE 362 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 363 INDIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 306 TABLE 364 INDIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 306 TABLE 365 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 306 TABLE 366 INDIA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 307 TABLE 367 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 307 TABLE 368 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 308 TABLE 369 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 370 JAPAN: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 309 TABLE 371 JAPAN: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 309 TABLE 372 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 310 TABLE 373 JAPAN: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 310 TABLE 374 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 311 TABLE 375 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 311 TABLE 376 SOUTH KOREA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 377 SOUTH KOREA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 312 TABLE 378 SOUTH KOREA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 313 TABLE 379 SOUTH KOREA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 313 TABLE 380 SOUTH KOREA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 314 TABLE 381 SOUTH KOREA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 314 TABLE 382 SOUTH KOREA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 315 TABLE 383 AUSTRALIA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 384 AUSTRALIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 316 TABLE 385 AUSTRALIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 316 TABLE 386 AUSTRALIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 316 TABLE 387 AUSTRALIA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 317 TABLE 388 AUSTRALIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 317 TABLE 389 AUSTRALIA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 318 TABLE 390 NEW ZEALAND: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 391 NEW ZEALAND: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 319 TABLE 392 NEW ZEALAND: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 319 TABLE 393 NEW ZEALAND: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 320 TABLE 394 NEW ZEALAND: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 320 TABLE 395 NEW ZEALAND: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 321 TABLE 396 NEW ZEALAND: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 321 TABLE 397 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 398 REST OF ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 323 TABLE 399 REST OF ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 323 TABLE 400 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 323 TABLE 401 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 324 TABLE 402 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 324 TABLE 403 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 325 TABLE 404 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS) 326 TABLE 405 LATIN AMERICA: KEY MACROINDICATORS 326 TABLE 406 LATIN AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 327 TABLE 407 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 408 LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 327 TABLE 409 LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 328 TABLE 410 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 328 TABLE 411 LATIN AMERICA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 329 TABLE 412 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 329 TABLE 413 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 330 TABLE 414 BRAZIL: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 415 BRAZIL: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 331 TABLE 416 BRAZIL: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 331 TABLE 417 BRAZIL: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 331 TABLE 418 BRAZIL: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 332 TABLE 419 BRAZIL: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 332 TABLE 420 BRAZIL: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 333 TABLE 421 MEXICO: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 422 MEXICO: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 334 TABLE 423 MEXICO: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 334 TABLE 424 MEXICO: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 334 TABLE 425 MEXICO: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 335 TABLE 426 MEXICO: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 335 TABLE 427 MEXICO: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 336 TABLE 428 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 429 REST OF LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 337 TABLE 430 REST OF LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 337 TABLE 431 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 337 TABLE 432 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 338 TABLE 433 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 338 TABLE 434 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 339 TABLE 435 MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS) 340 TABLE 436 MIDDLE EAST: KEY MACROINDICATORS 341 TABLE 437 MIDDLE EAST: EMPTY CAPSULES MARKET, BY REGION, 2023–2030 (USD MILLION) 341 TABLE 438 MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 439 MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 342 TABLE 440 MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 342 TABLE 441 MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 342 TABLE 442 MIDDLE EAST: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 343 TABLE 443 MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 343 TABLE 444 MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 344 TABLE 445 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 344 TABLE 446 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 447 GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 345 TABLE 448 GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 345 TABLE 449 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 346 TABLE 450 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 346 TABLE 451 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 347 TABLE 452 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 347 TABLE 453 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 454 SAUDI ARABIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 348 TABLE 455 SAUDI ARABIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 349 TABLE 456 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 349 TABLE 457 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 350 TABLE 458 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 350 TABLE 459 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 351 TABLE 460 UAE: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 461 UAE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 352 TABLE 462 UAE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 352 TABLE 463 UAE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 352 TABLE 464 UAE: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 353 TABLE 465 UAE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 353 TABLE 466 UAE: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 354 TABLE 467 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 468 REST OF GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 355 TABLE 469 REST OF GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 355 TABLE 470 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 355 TABLE 471 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 356 TABLE 472 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 356 TABLE 473 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 357 TABLE 474 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 475 REST OF MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 358 TABLE 476 REST OF MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 358 TABLE 477 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 358 TABLE 478 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 359 TABLE 479 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 359 TABLE 480 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 360 TABLE 481 AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (BILLION UNITS) 361 TABLE 482 AFRICA: KEY MACROINDICATORS 361 TABLE 483 AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 484 AFRICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 362 TABLE 485 AFRICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023–2030 (USD MILLION) 362 TABLE 486 AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 363 TABLE 487 AFRICA: EMPTY CAPSULES MARKET, BY SIZE, 2023–2030 (USD MILLION) 363 TABLE 488 AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023–2030 (USD MILLION) 364 TABLE 489 AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2023–2030 (USD MILLION) 364 TABLE 490 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN EMPTY CAPSULES MARKET, JANUARY 2022–JULY 2025 365 TABLE 491 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION 368 TABLE 492 EMPTY CAPSULES MARKET: REGION FOOTPRINT 373 TABLE 493 EMPTY CAPSULES MARKET: TYPE FOOTPRINT 374 TABLE 494 EMPTY CAPSULES MARKET: FUNCTIONALITY FOOTPRINT 375 TABLE 495 EMPTY CAPSULES MARKET: END-USER FOOTPRINT 376 TABLE 496 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 379 TABLE 497 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY TYPE AND REGION 380 TABLE 498 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 383 TABLE 499 EMPTY CAPSULES MARKET: DEALS, JANUARY 2022–JULY 2025 384 TABLE 500 EMPTY CAPSULES MARKET: EXPANSIONS, JANUARY 2022–JULY 2025 385 TABLE 501 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 386 TABLE 502 CAPSUGEL (LONZA): COMPANY OVERVIEW 387 TABLE 503 CAPSUGEL (LONZA): PRODUCTS OFFERED 388 TABLE 504 CAPSUGEL (LONZA): PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 390 TABLE 505 CAPSUGEL (LONZA): OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 391 TABLE 506 ACG: COMPANY OVERVIEW 392 TABLE 507 ACG: PRODUCTS OFFERED 393 TABLE 508 ACG: EXPANSIONS, JANUARY 2022–JULY 2025 394 TABLE 509 ACG: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 394 TABLE 510 QUALICAPS (ROQUETTE FRÈRES): COMPANY OVERVIEW 396 TABLE 511 QUALICAPS (ROQUETTE FRÈRES): PRODUCTS OFFERED 397 TABLE 512 QUALICAPS (ROQUETTE FRÈRES): DEALS, JANUARY 2022–JULY 2025 398 TABLE 513 QUALICAPS (ROQUETTE FRÈRES): EXPANSIONS, JANUARY 2022–JULY 2025 399 TABLE 514 SUHEUNG: COMPANY OVERVIEW 400 TABLE 515 SUHEUNG: PRODUCTS OFFERED 401 TABLE 516 SUHEUNG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 402 TABLE 517 HEALTHCAPS INDIA: COMPANY OVERVIEW 404 TABLE 518 HEALTHCAPS INDIA: PRODUCTS OFFERED 405 TABLE 519 NECTAR LIFESCIENCES LTD.: COMPANY OVERVIEW 406 TABLE 520 NECTAR LIFESCIENCES LTD.: PRODUCTS OFFERED 407 TABLE 521 NECTAR LIFESCIENCES LTD.: DEALS, JANUARY 2022–JULY 2025 407 TABLE 522 SUNIL HEALTHCARE LIMITED: COMPANY OVERVIEW 408 TABLE 523 SUNIL HEALTHCARE LIMITED: PRODUCTS OFFERED 409 TABLE 524 NATURAL CAPSULES LIMITED: COMPANY OVERVIEW 411 TABLE 525 NATURAL CAPSULES LIMITED: PRODUCTS OFFERED 412 TABLE 526 NATURAL CAPSULES LIMITED: DEALS, JANUARY 2022–JULY 2025 413 TABLE 527 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY OVERVIEW 414 TABLE 528 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCTS OFFERED 415 TABLE 529 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 415 TABLE 530 COMED CHEMICALS LIMITED: COMPANY OVERVIEW 416 TABLE 531 COMED CHEMICALS LIMITED: PRODUCTS OFFERED 417 TABLE 532 ANHUI HUANGSHAN CAPSULE CO., LTD.: COMPANY OVERVIEW 418 TABLE 533 ANHUI HUANGSHAN CAPSULE CO., LTD.: PRODUCTS OFFERED 419 TABLE 534 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY OVERVIEW 420 TABLE 535 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): PRODUCTS OFFERED 421 TABLE 536 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): DEALS, JANUARY 2022–JULY 2025 421 TABLE 537 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): COMPANY OVERVIEW 422 TABLE 538 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): PRODUCTS OFFERED 423 TABLE 539 CAPSCANADA: COMPANY OVERVIEW 424 TABLE 540 CAPSCANADA: PRODUCTS OFFERED 424 TABLE 541 FARMACÁPSULAS: COMPANY OVERVIEW 426 TABLE 542 FARMACÁPSULAS: PRODUCTS OFFERED 426 TABLE 543 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: COMPANY OVERVIEW 428 TABLE 544 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: PRODUCTS OFFERED 428 TABLE 545 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 429 TABLE 546 ERAWAT PHARMA LIMITED: COMPANY OVERVIEW 430 TABLE 547 ERAWAT PHARMA LIMITED: PRODUCTS OFFERED 430 TABLE 548 SAVIOURCAPS: COMPANY OVERVIEW 432 TABLE 549 SHANXI JC BIOLOGICAL TECHNOLOGY CO.: COMPANY OVERVIEW 433 TABLE 550 ROXLOR: COMPANY OVERVIEW 433 TABLE 551 MEDISCA INC.: COMPANY OVERVIEW 434 TABLE 552 ZHEJIANG YUEXI CAPSULE CO., LTD.: COMPANY OVERVIEW 435 TABLE 553 SHAOXING KANGKE CAPSULE CO., LTD.: COMPANY OVERVIEW 436 TABLE 554 ZHEJIANG HUILI CAPSULES CO., LTD.: COMPANY OVERVIEW 437 TABLE 555 SHAOXING ZHONGYA CAPSULE CO., LTD.: COMPANY OVERVIEW 438 TABLE 556 SHING LIH FANG ENTERPRISE CO., LTD.: COMPANY OVERVIEW 439 TABLE 557 LEFANCAPS: COMPANY OVERVIEW 440 TABLE 558 CHEMCAPS LIMITED: COMPANY OVERVIEW 441 TABLE 559 BIOCAPS ENTERPRISE: COMPANY OVERVIEW 441 TABLE 560 SNAIL PHARMA INDUSTRY: COMPANY OVERVIEW 442 TABLE 561 BRIGHT PHARMA CAPS: COMPANY OVERVIEW 443 TABLE 562 SHREE PHARMA CAPS: COMPANY OVERVIEW 444 TABLE 563 HEXIN CAPSULE CO., LTD.: COMPANY OVERVIEW 445 TABLE 564 WUHAN CARMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 446 TABLE 565 AIPAK PHARMA: COMPANY OVERVIEW 447 LIST OF FIGURES FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION & REGIONAL SCOPE 42 FIGURE 2 EMPTY CAPSULES MARKET: YEARS CONSIDERED 43 FIGURE 3 EMPTY CAPSULES MARKET: RESEARCH DESIGN 46 FIGURE 4 EMPTY CAPSULES MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS) 48 FIGURE 5 GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 49 FIGURE 6 GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024 50 FIGURE 7 GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VOLUME (2024) 51 FIGURE 8 GLOBAL EMPTY CAPSULES VOLUME-BASED MARKET SIZE ESTIMATION, BY VALUE (2024) 51 FIGURE 9 EMPTY CASPULES MARKET SIZE VALIDATION FROM PRIMARY EXPERTS 52 FIGURE 10 EMPTY CAPSULES SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH) 53 FIGURE 11 GLOBAL EMPTY CAPSULES MARKET: CAGR PROJECTIONS (2025–2030) 55 FIGURE 12 EMPTY CAPSULES MARKET: DATA TRIANGULATION METHODOLOGY 57 FIGURE 13 EMPTY CAPSULES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 60 FIGURE 14 GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2025 VS. 2030 (USD MILLION) 61 FIGURE 15 NON–GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2025 VS. 2030 (USD MILLION) 61 FIGURE 16 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2025 VS. 2030 (USD MILLION) 62 FIGURE 17 EMPTY CAPSULES MARKET, BY SIZE, 2025 VS. 2030 (USD MILLION) 63 FIGURE 18 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2025 VS. 2030 (USD MILLION) 63 FIGURE 19 EMPTY CAPSULES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 64 FIGURE 20 REGIONAL SNAPSHOT OF EMPTY CAPSULES MARKET 65 FIGURE 21 INCREASING DEMAND FOR NUTRACEUTICALS AND PERSONALIZED SUPPLEMENTS TO PROPEL MARKET GROWTH 68 FIGURE 22 US AND GELATIN CAPSULES COMMANDED LARGER MARKET SHARES IN 2024 69 FIGURE 23 ANTIBIOTIC & ANTIBACTERIAL DRUGS SEGMENT ACCOUNTED FOR LARGEST SHARE IN EMPTY CAPSULES MARKET IN 2024 69 FIGURE 24 PHARMACEUTICAL INDUSTRY HELD LARGEST MARKET SHARE IN 2024 70 FIGURE 25 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 70 FIGURE 26 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71 FIGURE 27 TOTAL PRESCRIPTION DRUG SALES, 2016−2030 (USD BILLION) 74 FIGURE 28 NUMBER OF CLINICAL TRIALS REGISTERED, 2001−2024 74 FIGURE 29 EMPTY CAPSULES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 FIGURE 30 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE, 2022−2024 (USD) 83 FIGURE 31 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2024 (USD) 84 FIGURE 32 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS 87 FIGURE 33 EMPTY CAPSULES MARKET: ECOSYSTEM ANALYSIS 89 FIGURE 34 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS 93 FIGURE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR EMPTY CAPSULES 95 FIGURE 36 KEY BUYING CRITERIA FOR EMPTY CAPSULES, BY END USER 97 FIGURE 37 TOTAL NUMBER OF PATENTS GRANTED, 2014−2024 100 FIGURE 38 TOP TEN PLAYERS/APPLICANTS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014−2024 100 FIGURE 39 EMPTY CAPSULES MARKET: VENTURE CAPITAL INVESTMENTS & NUMBER OF DEALS FOR SMALL MOLECULES, 2018–2024 (Q3) 119 FIGURE 40 AI USE CASES IN EMPTY CAPSULS MARKET 121 FIGURE 41 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT 253 FIGURE 42 ORAL SOLID DOSAGE (OSD) PERCENTAGE OF NOVEL DRUG APPROVAL, 2022–2024 258 FIGURE 43 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT 296 FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET, 2020–2024 (USD BILLION) 367 FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET (2024) 368 FIGURE 46 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 371 FIGURE 47 EMPTY CAPSULES MARKET: COMPANY FOOTPRINT 372 FIGURE 48 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 378 FIGURE 49 EV/EBITDA OF KEY VENDORS 381 FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 381 FIGURE 51 EMPTY CAPSULES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 382 FIGURE 52 CAPSUGEL (LONZA): COMPANY SNAPSHOT 388 FIGURE 53 ACG: COMPANY SNAPSHOT 393 FIGURE 54 QUALICAPS (ROQUETTE FRÈRES): COMPANY SNAPSHOT 397 FIGURE 55 SUHEUNG: COMPANY SNAPSHOT 400 FIGURE 56 HEALTHCAPS INDIA: COMPANY SNAPSHOT 404 FIGURE 57 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT 406 FIGURE 58 SUNIL HEALTHCARE LIMITED: COMPANY SNAPSHOT 409 FIGURE 59 NATURAL CAPSULES LIMITED: COMPANY SNAPSHOT 411 FIGURE 60 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY SNAPSHOT 414 FIGURE 61 COMED CHEMICALS LIMITED: COMPANY SNAPSHOT 416 FIGURE 62 ANHUI HUANGSHAN CAPSULE CO., LTD.: COMPANY SNAPSHOT 418 FIGURE 63 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY SNAPSHOT 420 FIGURE 64 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): COMPANY SNAPSHOT 422

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們